BREAKING NEWS 2024: Gene Editing's Pursuit of a CURE for HIV

The video discusses the FDA's approval of gene editing therapy for sickle cell disease and its challenges in accessibility. It explores CRISPR's potential in HIV treatment, citing Excision Biotherapeutics' promising trials and safety concerns regarding gene editing precision. Expert opinions emphasize cautious optimism while acknowledging safety assessments and distribution challenges. Despite hurdles, Excision's progress signals hope for innovative HIV treatments, akin to early strides in pivotal therapies, shaping a potential future without the virus.